Cha L. Lee

Toronto, ON M5S1Z5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis.

Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: January 20, 2025

Female Oncofertility and Immune Checkpoint Blockade in Melanoma: Where Are We Today?

Female Oncofertility and Immune Checkpoint Blockade in Melanoma: Where Are We Today?

Journal: Cancers

Published: December 02, 2024

Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models.

Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models.

Journal: International journal of molecular sciences

Published: November 21, 2024

Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine.

Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine.

Journal: Expert opinion on pharmacotherapy

Published: November 19, 2024

Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis.

Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis.

Journal: Endocrine-related cancer

Published: August 24, 2024

Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Journal: Cancers

Published: July 02, 2024

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.

Journal: Molecular cancer therapeutics

Published: July 16, 2023

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer.

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer.

Journal: Cancer biology & therapy

Published: June 16, 2023

Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.

Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.

Journal: World journal of gastroenterology

Published: August 14, 2022

Use of computed tomography sinography for evaluation of draining tracts in 27 dogs and one cat.

Use of computed tomography sinography for evaluation of draining tracts in 27 dogs and one cat.

Journal: The Journal of small animal practice

Published: January 15, 2021

Computed tomographic findings in 44 dogs and 10 cats with grass seed foreign bodies.

Computed tomographic findings in 44 dogs and 10 cats with grass seed foreign bodies.

Journal: The Journal of small animal practice

Published: June 17, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026